We are live on ! Find out more
JJ

Johnson & Johnson Portfolio holdings

AUM $799M
1-Year Est. Return 253.51%
This Fund
S&P 500
This Quarter Est. Return
+1.66%
1 Year Est. Return
+253.51%
3 Year Est. Return
+280.64%
5 Year Est. Return
+320.83%
10 Year Est. Return
–
AUM
$342M
AUM Growth
-$44.3M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
97.19%
Holding
20
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PTGX icon
1
Protagonist Therapeutics
PTGX
$9.8B
$118M 34.65%
2,449,183
– –
CVRX icon
2
CVRx
CVRX
$78.3M
$50.2M 14.68%
4,103,430
– –
MGTX icon
3
MeiraGTx Holdings
MGTX
$1.17B
$45M 13.17%
6,641,064
– –
LEGN icon
4
Legend Biotech
LEGN
$3.93B
$27.6M 8.08%
814,586
– –
RAPP
5
Rapport Therapeutics
RAPP
$2.27B
$25.1M 7.33%
2,498,051
– –
PRCT icon
6
Procept Biorobotics
PRCT
$1.26B
$20.9M 6.1%
357,939
– –
NBTX
7
Nanobiotix
NBTX
$1.94B
$20.1M 5.89%
5,623,816
– –
CTNM
8
Contineum Therapeutics
CTNM
$576M
$13.8M 4.04%
1,979,173
– –
XNCR icon
9
Xencor
XNCR
$1.71B
$7.96M 2.33%
748,062
– –
ARWR icon
10
Arrowhead Research
ARWR
$12.1B
$3.15M 0.92%
247,598
– –
FATE icon
11
Fate Therapeutics
FATE
$294M
$2.67M 0.78%
3,379,064
– –
RLYB icon
12
Rallybio
RLYB
$90.1M
$2.38M 0.7%
454,545
– –
NMRA icon
13
Neumora Therapeutics
NMRA
$321M
$1.85M 0.54%
1,849,445
– –
NNOX icon
14
Nano X Imaging
NNOX
$73.2M
$793K 0.23%
158,852
– –
VOR icon
15
Vor Biopharma
VOR
$1.38B
$771K 0.23%
53,733
– –
LYEL icon
16
Lyell Immunopharma
LYEL
$337M
$443K 0.13%
41,166
– –
LAB icon
17
Standard BioTools
LAB
$294M
$337K 0.1%
311,967
– –
ACET icon
18
Adicet Bio
ACET
$77.3M
$275K 0.08%
22,780
– –
PHGE icon
19
BiomX
PHGE
$1.67M
$53.8K 0.02%
5,098
– –
SENS icon
20
Senseonics Holdings Inc
SENS
$409M
$35.8K 0.01%
2,731
– –

Similar funds

HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return
UM
Ulysses Management New York $802M AUM 5.35% 1-Year Est. Return
RIM
Redwood Investment Management Scottsdale, Arizona $805M AUM 15.01% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
AI
Aperture Investors New York $791M AUM 54.66% 1-Year Est. Return

Johnson & Johnson's Q1 2025 Portfolio in Review

As of Q1 2025, Johnson & Johnson held 20 positions worth $342M, down 11% from $386M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

Trading was light in Q1 2025: portfolio turnover was 0%. Johnson & Johnson opened no new positions and made no exits, leaving the 20-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Johnson & Johnson's ten largest holdings make up 97% of its $342M portfolio in Q1 2025.
  • Johnson & Johnson opened 0 new positions and closed 0 in Q1 2025.
  • Johnson & Johnson's portfolio value fell 11% quarter-over-quarter to $342M.

Based on Johnson & Johnson's 13F filing for Q1 2025, filed 7 May 2025.